MEF2A and pulmonary hypertension: Kim et al. [18] demonstrated that the activities of MEF2A and MEF2C in pulmonary artery endothelial cells from patients with pulmonary hypertension (PAH) is significantly impaired, and that the recovery of MEF2A and MEF2C can rescue the cellular phenotype from PAH.